期刊文献+

转移相关蛋白1和埃兹蛋白在膀胱尿路上皮癌中的表达 被引量:1

Expression of metastasis-associated protein 1 and Ezrin in bladder urothelial carcinoma
原文传递
导出
摘要 目的 检测转移相关蛋白1(MTA-1)、埃兹蛋白(Ezrin)在膀胱尿路上皮癌(BUC)组织及正常膀胱黏膜组织中的表达,探讨两者与患者临床病理及预后之间的关系.方法 采用免疫组化法检测65例手术切除的BUC组织和30例正常膀胱黏膜组织中MTA-1和Ezrin蛋白表达,分析MTA-1和Ezrin在BUC中的表达与患者临床病理参数的关系,分析MTA-1和Ezrin表达之间的相关性和对患者预后的影响.结果 65例BUC组织中MTA-1和Ezrin阳性表达率分别为72.3%(47/65)和89.2%(58/65),30例正常膀胱黏膜组织MTA-1和Ezrin阳性表达率均为0,差异有统计学意义(均P<0.01).BUC组织中,MTA-1表达与临床分期、肿瘤病理分级、有无转移、是否复发有关(均P<0.01),Ezrin表达与临床分期、肿瘤有无转移、是否复发有关(均P<0.01),MTA-1与Ezrin的表达呈正相关(r=0.742,P<0.01).MTA-1和Ezrin联合表达组的无病生存率明显低于联合阴性表达组(P<0.01).结论 MTA-1和Ezrin蛋白高表达与BUC发生发展、侵袭和转移有关. Objective To detect the expression of metastasis- associated protein 1 (MTA- 1) and Ezrin in bladder urothelial carcinoma (BUC) and normal bladder mucosa, and to investigate their correlation with clinical pathology and prognosis. Methods The expression of MTA- 1 and Ezrin proteins was detected in 65 specimens of surgically resected BUC tissue and 30 of normal bladder mucosa with immunohistochemistry. The correlation of MTA- 1 and Ezrin expressions in BUC with clinicopathological parameters, the correlation between MTA-1 and Ezrin protein expressions and their effects on prognosis were also analyzed. Results In 65 specimens of BUC tissue, the positive rates of MTA- 1 and Ezrin expression were 72.3% (n=47) and 89.2% (n=58) , respectively, in contrast to 0% for both MTA- 1 and Ezrin expressions in 30 specimens of normal bladder mucosa, which reached the level of statistical difference (all P〈0.01). The expression of MTA- 1 in BUC tissue was closely related to the clinical stages, tumor pathological grading, metastasis and recurrence (all P〈0.01 ) , while the expression of Ezrin was closely related to the clinical stages, metastasis and recurrence (all P〈0.01 ), and the expression of MTA-1 was positively correlated with Ezrin expression (r=0.742, P〈0.01 ). The disease free survival (DFS) in patients with combined expression was significantly lower than that in those with negative expression of MTA- 1 and Ezrin (P〈0.01). Conclusion The high expression of MTA-1 and Ezrin is related to the occurrence,progression, as well as invasion and metastasis of BUC.
出处 《中华生物医学工程杂志》 CAS 2010年第6期526-529,共4页 Chinese Journal of Biomedical Engineering
关键词 膀胱肿瘤 病理学 临床 免疫组织化学 肿瘤转移过程相关蛋白质 Bladder neoplasms Pathology, clinical Immunohistochemistry Tumormetastatic process-associated protein
  • 相关文献

参考文献10

  • 1Toh Y, Ohga T, Endo K, et al. Expression of the metastasis associated MTAl protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer, 2004, 110: 362-367.
  • 2唐正严,杨罗艳,齐琳,叶章群,周四维,祖雄兵.膀胱移行细胞癌Mta-1表达及与ER、u-PA/PAI-1、MVD的相关性研究[J].中华泌尿外科杂志,2006,27(7):468-471. 被引量:9
  • 3陈耀勇,李冰,宋春林,付欣,邹东霆.5个不同肺癌细胞株的基因差异表达谱[J].中国现代医学杂志,2002,12(24):14-17. 被引量:4
  • 4Kumar R, Wang RA, Bagheri- Yarmand R. Emerging roles of MTA family members in human cancers. Semin Oncol, 2003, 30 (5 Suppl 16): 30-37.
  • 5Wan X, Mendoza A, Khanna C, et al. Rapamycin inhibits ezrin- mediated metastatic behavior in a murine model of osteosarcoma. Cancer Res, 2005, 65: 2406-2411.
  • 6李琼,吴明富,宋安萍,魏军成,徐刚,卢运萍,马丁.浸润性乳腺导管癌组织中Ezrin和钙粘素E的表达与淋巴结转移的关系[J].癌症,2006,25(3):363-366. 被引量:53
  • 7Kobel M, Langhammer T, Huttelmaier S, et al. Ezrin expression is related to poorprognosis in FIGO stage I endometrioid carcinomas. Mod Pathol, 2006, 19: 581-587.
  • 8Valdman A, Fang X, Pang ST, et al. Ezrin expression in prostate cancer and benign prostatic tissue. Eur Urol, 2005,48: 852-857.
  • 9Bretscher A, Edwards K, Fehon RG, et al. ERM proteins and merlin : integrators at the cell cortex. Nat Rev Mol Cell Biol, 2002, 3: 586-599.
  • 10Fujita N, Jaye DL, Kajita M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell, 2003, 113: 207-219.

二级参考文献35

  • 1武文森,尹克静,张荣久,张爱华.BBN诱发大鼠膀胱肿瘤实验研究[J].肿瘤防治研究,1993,10(1):23-25. 被引量:4
  • 2Martin T A, Harrison G, Mansel RE, et al. The role of the CD44/ezrin complex in cancer metastasis [J]. Crit Rev Oncol Hematol, 2003,46(2) : 165-186.
  • 3McClatchey A I. Merlin and ERM proteins: unappreciated roles in cancer development? [J]. Cancer, 2003,3 (11):877-884.
  • 4Bretscher A, Edwards K, Fehon R G, et al. ERM proteins and merlin: integrators at the cell cortex [J ]. Nature Rev Mol Cell Biol, 2002,3(8) :586-599.
  • 5Charpin C, Garcia S, Bouvier C, et al. E-CD quantitative immunohistochemistry assays in breast carcinomas [J]. J Pathol, 1997, 181 (3) : 294-300.
  • 6Hiscox S, Jiang W G. Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with Ecadherin/b-catenin[J]. J Cell Sci, 1999,112(18):3081-3090.
  • 7Pujuguent P, Del Maestro L, Gautreau A, et al. Ezrin regulates E-Cadherin-dependent adherens junction assembly through Racl activation [J]. Mol Biol Cell, 2003,14 (5):2181-2191.
  • 8Yu Y, Khan J, Khanna C, et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators[J]. Nat Med, 2004,10(2): 175-256.
  • 9Khanna C, Wan X, Bose S, et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis [J]. Nat Med, 2004,10(2) : 182-188.
  • 10Nestl A, Von Stein O D, Zatloukal K, et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors [J]. Cancer Res, 2001,61 (4):1569-1577.

共引文献63

同被引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部